Thai researchers have developed and registered a domestically produced botulinum antitoxin, cutting treatment costs while strengthening the country’s pharmaceutical security and emergency preparedness. On 28 July, Deputy Government Spokesperson Ploytalay Laksameesangchan announced that the Thai Food and Drug Administration had […]
Private hospitals are seeing an increase in dengue admissions this year, mirroring trends at public hospitals... Read More
Building a dementia-ready Malaysia by 2030 requires coordinated efforts from communities alongside government... Read More
The care economy goes beyond welfare and charity and is a revenue-generating sector cutting across employment... Read More
Nearly one in four government specialists whose applications for sub-specialist training were rejected... Read More
Leukaemia, a cancer of the blood and bone marrow, remains among the top 10 most common cancers in Malaysia... Read More
The health ministry is establishing a special task force on drug and medical device safety to be better prepared to face global supply... Read More
Healthcare professionals, buyers, and industry leaders from across the globe will gather in Bangkok from 10 to 12 September 2025... Read More
As we strive to be the hospital of choice, why not refine our commitment to excellence beyond the pivotal mission of saving lives... Read More